TY  - JOUR

T1  - OSTEOPROTEGERIN DERIVED FROM TUMOUR CELLS OR FROM BONE MARROW CELL TYPES DIFFERS IN ITS ACTIVITY AS A SURVIVAL FACTOR FOR PROSTATE CANCER

JO  - European Urology Supplements

UR  - https://doi.org/10.1016/s1569-9056(06)60414-4

PY  - 2006/04/01

AU  - Cross N

AU  - Waterman E

AU  - Jokonya N

AU  - Holen I

AU  - Hamdy F

AU  - Eaton C

ED  - 

DO  - DOI: 10.1016/s1569-9056(06)60414-4

PB  - Elsevier BV

VL  - 5

IS  - 2

SP  - 124

EP  - 124

Y2  - 2025/11/04

ER  -